or Try an Advanced Search...

    Technical Analysis for VOR - Vor Biopharma Inc.

    Grade Last Price % Change Price Change
    D 0.80 -4.17% -0.04
    VOR closed down 4.17 percent on Friday, November 1, 2024, on 40 percent of normal volume. It was able to find support at its 50 day moving average.
    Earnings due: Nov 5
    *** please verify all earnings dates ***
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Flat Up
    Historical VOR trend table...
    Date Alert Name Type % Chg
    50 DMA Support Bullish 0.00%
    MACD Bullish Centerline Cross Bullish 0.00%
    Upper Bollinger Band Walk Strength 0.00%
    Inside Day Range Contraction 0.00%
    Upper Bollinger Band Touch Strength 0.00%
    Crossed Above 50 DMA Bullish -4.17%
    Expansion Pivot Buy Setup Bullish Swing Setup -4.17%
    Pocket Pivot Bullish Swing Setup -4.17%
    Upper Bollinger Band Walk Strength -4.17%
    Above Upper BB Strength -4.17%
    Older End-of-Day Signals for VOR ...

       Recent Intraday Alerts

    Alert Time
    Possible Inside Day about 20 hours ago
    50 DMA Support about 21 hours ago
    60 Minute Opening Range Breakdown about 21 hours ago
    Down 3% about 21 hours ago
    Fell Below 50 DMA about 21 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    VOR Chart by TradingView
    Basic chart:

    Profile

    Vor Biopharma, Inc. develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It offers VOR33, an eHSC product candidate that is in preclinical development to treat acute myeloid leukemia (AML). The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AML cancer cells. Vor Biopharma, Inc. was incorporated in 2015 and is based in Cambridge, Massachusetts.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Cancer Acute Myeloid Leukemia Tyrosine Kinase Receptors Therapies For Cancer Proteins Haematopoiesis Lintuzumab

    Is VOR a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Sep 30 Vor Bio Appoints Seasoned Healthcare Institutional Investor, Han Choi, M.D., LL.M., as Chief Financial Officer
    Sep 5 Vor Bio stock rallies post-market on trem-cel study data
    Sep 5 New Clinical Data Validates Vor Bio’s Approach of Using Shielded Transplants to Deliver Targeted Therapies
    Sep 5 Here's Why Vor Biopharma (NASDAQ:VOR) Must Use Its Cash Wisely
    Aug 9 Vor Biopharma GAAP EPS of -$0.41
    Aug 8 Vor Bio Reports Second Quarter 2024 Financial Results and Provides Company Update
    May 10 Vor Biopharma GAAP EPS of $0.45
    May 9 Vor Bio Reports First Quarter 2024 Financial Results and Provides Company Update
    May 3 Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    May 2 Vor Bio Appoints Accomplished Oncology and Cancer Immunotherapy R&D Executive, Fouad Namouni, M.D., to its Board of Directors
    See more VOR news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 3.1399
    52 Week Low 0.63
    Average Volume 1,100,062
    200-Day Moving Average 1.41
    50-Day Moving Average 0.80
    20-Day Moving Average 0.71
    10-Day Moving Average 0.74
    Average True Range 0.07
    RSI (14) 58.33
    ADX 24.96
    +DI 26.52
    -DI 11.30
    Chandelier Exit (Long, 3 ATRs) 0.71
    Chandelier Exit (Short, 3 ATRs) 0.84
    Upper Bollinger Bands 0.81
    Lower Bollinger Band 0.61
    Percent B (%b) 0.97
    BandWidth 28.71
    MACD Line 0.00
    MACD Signal Line -0.02
    MACD Histogram 0.0236
    Fundamentals Value
    Market Cap 54.57 Million
    Num Shares 67.8 Million
    EPS -1.89
    Price-to-Earnings (P/E) Ratio -0.43
    Price-to-Sales 0.00
    Price-to-Book 0.89
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.91
    Resistance 3 (R3) 0.92 0.90 0.89
    Resistance 2 (R2) 0.90 0.87 0.89 0.89
    Resistance 1 (R1) 0.85 0.85 0.84 0.84 0.88
    Pivot Point 0.83 0.83 0.82 0.82 0.83
    Support 1 (S1) 0.78 0.80 0.77 0.77 0.73
    Support 2 (S2) 0.75 0.78 0.75 0.72
    Support 3 (S3) 0.71 0.75 0.72
    Support 4 (S4) 0.70